These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 14037969)
21. Thrombophlebitis of the superficial and deep veins treated with phenylbutazone (butazolidin). ORBACH EJ J Int Coll Surg; 1959 Feb; 31(2):165-8. PubMed ID: 13641724 [No Abstract] [Full Text] [Related]
22. Cardiovascular actions of butazolidin in experimental animals. GAITONDE BB; KULKARNI RD; PATEL JR; DADKAR SN Indian J Med Sci; 1963 Jun; 17():473-8. PubMed ID: 13946156 [No Abstract] [Full Text] [Related]
23. The value of phenylbutazone (butazolidin) in generalized osteoarthritis. RAMOS JM R I Med J; 1959 Apr; 42(4):249-50. PubMed ID: 13646449 [No Abstract] [Full Text] [Related]
24. [Combined use of butazolidin (phenylbutazone) and some corticosteroids in experimental inflammations]. WILHELMI G Schweiz Med Wochenschr; 1958 Feb; 88(8):185-8. PubMed ID: 13543303 [No Abstract] [Full Text] [Related]
25. Field trials of nivaquine, camoquin and resochin against human malaria. DUTTA CP; PRADHAN J; BHATTACHARJEE SK Indian J Malariol; 1954 Sep; 8(3):219-27. PubMed ID: 14353526 [No Abstract] [Full Text] [Related]
26. [The osmotic behavior of normal, of inflamed, and of 1,2-diphenyl-4-butyl-3,5-pyrazolidinedione-treated rat liver slices]. BURCK HC Arzneimittelforschung; 1960 Sep; 10():752-5. PubMed ID: 13688929 [No Abstract] [Full Text] [Related]
27. [Comparison between phenylbutazone and ketophenylbutazone]. CUGURRA F; BRAMBILLA G Arch Ital Sci Farmacol; 1960 Jul; 10():195-207. PubMed ID: 13718791 [No Abstract] [Full Text] [Related]
28. Preferential and non-selective cyclooxygenase inhibitors reduce inflammation during lipopolysaccharide-induced synovitis. Morton AJ; Campbell NB; Gayle JM; Redding WR; Blikslager AT Res Vet Sci; 2005 Apr; 78(2):189-92. PubMed ID: 15563928 [TBL] [Abstract][Full Text] [Related]
29. [Melanosis due to camoquin]. YOUNG E Ned Tijdschr Geneeskd; 1958 Jun; 102(23):1088-92. PubMed ID: 13566294 [No Abstract] [Full Text] [Related]
30. Camoquin in amoebic liver abscess. GORDON G; WILMOT AJ; ELSDONDEW R J Trop Med Hyg; 1955 Jun; 58(6):133-5. PubMed ID: 14392681 [No Abstract] [Full Text] [Related]
32. 4 (3'-Diethylamino-methyl-4'-hydroxyanilino)-7-chloroquinoline (camoquin) in the treatment of giardiasis. KONAR NR; SEN GUPTA AN; BHATTACHARJEE SP; CHANDA G J Indian Med Assoc; 1953 Nov; 23(2):52-4. PubMed ID: 13109202 [No Abstract] [Full Text] [Related]
33. [Preliminary findings on the existence of taeniasis in Portuguese Guinea and a therapeutic trial with camoquin]. DE LECUONA MO An Inst Med Trop (Lisb); 1956; 13(1-2):87-96. PubMed ID: 13411519 [No Abstract] [Full Text] [Related]
34. [Experimental studies on influencing antibody formation by butazolidin]. ROTHER K; KATZ F Arch Int Pharmacodyn Ther; 1957 Oct; 112(1-2):65-72. PubMed ID: 13498839 [No Abstract] [Full Text] [Related]
35. Preliminary clinical report on delta-butazolidin (geigy). MORIARTY MA J Ir Med Assoc; 1959 Apr; 44(262):114-6. PubMed ID: 13641845 [No Abstract] [Full Text] [Related]
36. Inactivation of alpha1-antiproteinase induced by phenylbutazone: participation of peroxyl radicals and hydroperoxide. Muraoka S; Miura T Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):261-6. PubMed ID: 16930300 [TBL] [Abstract][Full Text] [Related]
37. Fixed drug eruption in Nigeria. Nnoruka EN; Ikeh VO; Mbah AU Int J Dermatol; 2006 Sep; 45(9):1062-5. PubMed ID: 16961509 [TBL] [Abstract][Full Text] [Related]
38. Effects of phenylbutazone alone or in combination with flunixin meglumine on blood protein concentrations in horses. Reed SK; Messer NT; Tessman RK; Keegan KG Am J Vet Res; 2006 Mar; 67(3):398-402. PubMed ID: 16506899 [TBL] [Abstract][Full Text] [Related]
39. The sugar transport system in striated muscle. Effect of growth hormone, hydrocortisone and alloxan diabetes. RIDDICK FA; REISLER DM; KIPNIS DM Diabetes; 1962; 11():171-8. PubMed ID: 14038690 [No Abstract] [Full Text] [Related]